Related Experiment Videos
Prospective, randomized study of the efficacy of Mepitel on children with partial-thickness scalds
C S Gotschall1, M I Morrison, M R Eichelberger
1Emergency Trauma Services, Children's National Medical Center, Washington, DC 20010-2970, USA.
Insights
Mepitel significantly speeds healing and reduces pain for children with partial-thickness scald burns compared to silver sulfadiazine. This innovative treatment also lowers healthcare costs without increasing infection rates.
Area of Science:
- Pediatric Burn Care
- Wound Management
- Clinical Trials
Background:
- Partial-thickness scald burns are common in children.
- Current treatments like silver sulfadiazine have limitations.
- Optimizing healing and patient comfort is crucial.
Purpose of the Study:
- To compare the efficacy of Mepitel versus silver sulfadiazine in treating pediatric partial-thickness scald burns.
- To evaluate differences in healing time, pain, infection, and resource utilization.
Main Methods:
- Randomized clinical trial involving children with <15% total body surface area scald burns.
- Treatment groups: Mepitel vs. silver sulfadiazine.
- Outcome measures: time to healing, pain, infection, resource use; analyzed with t-tests, chi-square, and Kaplan-Meier curves.
Main Results:
- Mepitel group showed significantly faster wound healing (p < 0.001).
- Reduced eschar formation (p < 0.05) and less pain during dressing changes (p < 0.05) in the Mepitel group.
- Significantly lower mean daily hospital charges ($1937 vs $2316; p = 0.025) and dressing/narcotic costs with Mepitel.
- No significant difference in wound infection rates between groups.
Conclusions:
- Mepitel is a superior treatment for pediatric partial-thickness scald burns, offering faster healing and reduced pain.
- Mepitel provides significant cost savings in healthcare resource utilization.
- The use of Mepitel represents a significant advancement in pediatric burn wound care.
Abstract:
We performed a randomized clinical trial in which children with partial-thickness scald burns of less than 15% total body surface area were assigned treatment with either Mepitel (Mölnlycke Health Care) or silver sulfadiazine. Data were collected on time to wound healing, pain at dressing change, infection, and resource use. Student's t and chi-square tests were used to determine differences in the two groups. Healing times were compared using Kaplan-Meier survival curves. Wounds of children treated with Mepitel healed significantly faster than did controls' (p < 0.001), exhibited less eschar formation (p < 0.05), and experienced less pain at dressing change (p < 0.05). They also had significantly lower mean daily hospital charges ($1937 vs $2316; p = 0.025); as well as significantly lower charges for dressing changes and narcotics. There was no significant difference in wound infection. We believe the use of Mepitel represents a significant advance in the treatment of partial-thickness scald wounds in children.